Flow cytometric analysis reveals immune dysregulation in smoking-associated periodontitis, indicating potential treatments.
Introduction: Periodontitis involves chronic immune dysregulation, with Th17/Treg imbalance contributing to disease progression. Smoking further disrupts immune homeostasis, exacerbating inflammatory pathways. Methods: Forty-five participants were divided into three groups: healthy controls, non-smokers with periodontitis, and smokers with periodontitis. Flow cytometry quantified Th17 (CD4 + IL-17A + ) and Treg (CD4 + CD25 + FOXP3 + ) cells. qRT-PCR assessed IL-17, FOXP3, IL-12A, and hEIB3 gene expression in gingival tissues. Results: Th17 cells were markedly increased in smokers (1.31%) versus non-smokers (0.93%) and controls (0.26%). Treg cells increased in disease groups but were functionally unstable in smokers. hEIB3 expression was lowest in smokers, indicating impaired IL-35–mediated regulation. Conclusions: Smoking amplifies immune dysregulation in periodontitis by increasing Th17 activity and diminishing Treg stability. Immunomodulatory and cessation strategies may enhance periodontal outcomes.
No takes yet. Share an insight, caveat, or question.
Sidharthan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: